Categories AlphaGraphs, Earnings, Leisure & Entertainment
Dave & Buster’s (PLAY) Q3 profit drops despite higher revenues; comp sales up 13.3%
Dave & Buster’s Entertainment, Inc. (NASDAQ: PLAY), which operates a chain of casual dining and leisure facilities, reported a sharp fall in third-quarter earnings, despite a double-digit increase in revenues. Comparable-store sales increased at a faster pace.
The Dallas-based company reported a net income of $1.92 million or $0.04 per share for the October quarter, up 82% from the prior-year profit of $10.6 million or $0.21 per share. Adjusted EBITDA moved up 32% annually to $89.9 million.
Meanwhile, third-quarter revenues climbed 51% year-over-year to $481.2 million, reflecting a 13.3% growth in comparable store sales. Both operating segments — Food and Beverages and Amusement and Other — registered double-digit growth.
Check this space to read management/analysts’ comments on Dave & Buster’s Q3 results
“Our outstanding team continues to strongly execute our integration plan and deliver exceptional results, despite the challenging macro and inflationary environment. We remain focused on driving innovation, growth, and value creation for our stakeholders. The future is incredibly bright for this new organization, and I am excited about sharing our progress with you over the next few years,” said Chris Morris, chief executive officer of Dave & Buster’s Entertainment.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Nike (NKE) looks set to beat hurdles and build a brighter future
Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business
Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company
Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications